Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Price:
10.42 USD
3.17%
Updated:
May 9, 2024
Phathom Pharmaceuticals Inc
Operating Expenses
|
Phathom Pharmaceuticals Inc
Operating Expenses Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
|
Operating Expenses
-$167.8m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-167%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Operating Expenses
-$35.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Operating Expenses
-$24.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-11%
|
|
|
Pfizer Inc
NYSE:PFE
|
Operating Expenses
-$28.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-2%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Operating Expenses
-$39.8B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-8%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Operating Expenses
-$17.5B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-4%
|
See Also
What is Phathom Pharmaceuticals Inc's Operating Expenses?
Operating Expenses
-167.8m
USD
-167.8m
USD
Based on the financial report for Dec 31, 2023, Phathom Pharmaceuticals Inc's Operating Expenses amounts to -167.8m USD.
What is Phathom Pharmaceuticals Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-167%
-167%
Over the last year, the Operating Expenses growth was 3%. The average annual Operating Expenses growth rates for Phathom Pharmaceuticals Inc have been -10% over the past three years , -167% over the past five years .
You don't have any saved screeners yet
